188777-95-9

Basic information

• Product Name: 2,11-DIMETHYLDODECANEDIOIC ACID
• Synonyms: 2,11-DIMETHYLDODECANEDIOIC ACID
• CAS NO: 188777-95-9
• Molecular Formula: C14H26O4
• Molecular Weight: 258.35
• Mol File: 188777-95-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,11-DIMETHYLDODECANEDIOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2,11-DIMETHYLDODECANEDIOIC ACID(188777-95-9)
• EPA Substance Registry System: 2,11-DIMETHYLDODECANEDIOIC ACID(188777-95-9)

Safety Data

• Hazardous Substances Data: 188777-95-9(Hazardous Substances Data)

Upstream product

• 4549-32-0 1,8-dibromooctane 
• 802294-64-0 propionic acid 

Relevant articles and documents

LIPID PRODRUGS OF NEUROSTEROIDS

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.

LIPID PRODRUGS OF JAK INHIBITORS AND USES THEREOF

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.

LIPID PRODRUGS OF GLUCOCORTICOIDS AND USES THEREOF

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.